BioSpace News Archive

Altimmune, Inc. announced that Dr. Scott Harris, Chief Medical Officer at Altimmune, has been invited to participate on a Metabolic panel at the Healthcare Virtual Conference Part II, presented by Maxim Group LLC and hosted by M-Vest, on Tuesday, June 20th, 2023 at 11:00 A.M. ET.

Abcam plc, a global leader in the supply of life science research tools, filed and mailed a shareholder circular calling an Extraordinary General Meeting to be held on July 12, 2023 at 2:00pm || 9:00am.

Clene Inc., along with its subsidiaries “Clene” and its wholly owned subsidiary Clene Nanomedicine, Inc., a clinical-stage biopharmaceutical company focused on revolutionizing the treatment of neurodegenerative disease, announced the pricing of an underwritten public offering of 50,000,000 shares of its common stock and two tranches of warrants.

Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines, today announced that the Company will present in a fireside chat at the TD Cowen Radiopharmaceutical Innovation Summit on Tuesday, June 20, 2023 at 11:30 a.m. ET.

Panbela Therapeutics, Inc. announced the pricing of a public offering of 2,270,000 shares of its common stock or pre-funded warrants in lieu thereof and two classes of warrants to purchase up to an aggregate of 4,540,000 shares of its common stock at a purchase price of $3.75 per share and associated Public Warrants.

VIVEX Biologics, Inc., a leading regenerative medicine company specializing in the development of naturally sourced treatments, announced that the Centers for Medicare and Medicaid Services has assigned a Q-code for its CYGNUS® Dual amniotic allograft product.

Microbot Medical Inc. is encouraged by the continued participation and level of enthusiasm being demonstrated by the Key Opinion Leaders globally who are using the LIBERTY® Robotic Surgical System during the Company’s pre-clinical animal studies.

Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) (“Defence” or the “Company”), a Canadian biopharmaceutical company specialized in the development of immune-oncology vaccines and drug delivery technologies

Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the “Company” or “Sona”), a nanotechnology company developing pre-clinical Targeted Hyperthermia Therapy for colorectal cancer, is pleased to announce the selection of Minnetronix Medical to engineer the second generation of its infrared light device.

Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage company and leader in cell therapeutics, today announced it will be participating in the upcoming symposia-cel Truist Securities Cell Therapy Symposium being held June 27, 2023 in New York City.